Safety and Efficacy of the Subclavian Approach for Transcatheter Aortic Valve Implantation With the CoreValve Revalving System.

The article presents a study that determined the feasibility of a trans-subclavian approach for transcatheter aortic valve implantation (TAVI) with CoreValve revalving system on patients with cases of unfavorable iliofemoral anatomy or extensive disease. TAVI with the CoreValve bioprosthesis were performed in 514 patients at 13 Italian hospitals using the subclavian approach in 54 cases. Results showed feasibility and safety of the subclavian approach with excellent procedural success and low in-hospital complications.